MINNEAPOLIS, Sept. 18,
2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:
TECH) today issued its 2024 Corporate Sustainability Report (CSR),
detailing the continued progress advancing its Environmental,
Social and Governance (ESG) initiatives. Bio-Techne's CSR is
organized around four key pillars: Our People, Advancing Science,
Governance and Operational Integrity, and The Environment.
Bio-Techne's EPIC values (Empowerment, Passion, Innovation and
Collaboration) remain the backbone of our corporate culture and
provide the foundation for our approach to continuously improving
our corporate sustainability. The updated CSR is available in the
Corporate and Social Responsibility section of Bio-Techne's
website.
"I am proud of the progress the team continues to make
positioning Bio-Techne for a sustainable future," said Kim Kelderman, President and Chief Executive
Officer of Bio-Techne. "Our global team remains committed to
enriching the communities we live and work in, while delivering the
innovation the scientific community relies on to catalyze advances
in science and medicine. These are achieved while functioning at
the highest level of governance and operational integrity. This
focus enables the team to grow the organization in a responsible
manner and deliver the products necessary to develop and advance
the next generation of therapeutics, vaccines and diagnostics that
improve global healthcare."
"This latest CSR includes several noteworthy advancements in our
sustainability journey," commented Shane
Bohnen, Chief Sustainability Officer, General Counsel and
Corporate Secretary. "Specifically, we submitted a letter of
commitment to reduce our Scope 1, 2 and 3 greenhouse gas emissions,
and our reduction targets will be evaluated by the Science Based
Targets Initiative (SBTI) in 2026. We also completed our first
EcoVadis sustainability assessment to evaluate our performance in
environment, labor and human rights, ethics and sustainable
procurement, and earned a Bronze Medal in this inaugural
evaluation, putting us in the top 67% of all companies assessed. I
am looking forward to sharing the team's continued progress
furthering our sustainability initiatives."
About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH)
is a global life sciences company providing innovative tools and
bioactive reagents for the research and clinical diagnostic
communities. Bio-Techne products assist scientific investigations
into biological processes and the nature and progress of specific
diseases. They aid in drug discovery efforts and provide the means
for accurate clinical tests and diagnoses. With hundreds of
thousands of products in its portfolio, Bio-Techne generated
approximately $1.2 billion in net
sales in fiscal 2024 and has approximately 3,100 employees
worldwide. For more information on Bio-Techne and its brands,
please visit https://www.bio-techne.com or follow the Company on
social media at: Facebook, LinkedIn, Twitter or YouTube.
About Bio-Techne Corporation (NASDAQ: TECH)
Contact: David Clair, Vice
President, Investor Relations
david.clair@bio-techne.com
612-656-441
View original content to download
multimedia:https://www.prnewswire.com/news-releases/bio-techne-issues-2024-corporate-sustainability-report-302249719.html
SOURCE Bio-Techne Corporation
